# Burlington Stores, Inc.: financial statements, quarterly

BURL · NYSE · CIK 1579298 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Feb 1

Pages: [Overview](/companies/burl.md) · [Financials](/companies/burl/financials.md) · [Filings](/companies/burl/filings.md) · [Insiders](/companies/burl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/burl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,285](/filings/0000950170-24-131050.md) | [3,121 d](/filings/0001193125-26-116001.md) | [2,357](/filings/0000950170-25-079172.md) | [2,461](/filings/0001579298-25-000010.md) | [2,526](/filings/0001193125-25-297249.md) | [3,272 d](/filings/0001193125-26-116001.md) | [2,500](/filings/0001193125-26-245274.md) | [2,701](/filings/0001193125-26-371311.md) | [2,706](/filings/0001193125-25-297249.md) | [3,643 d](/filings/0001193125-26-116001.md) | [2,852](/filings/0001193125-26-245274.md) | [2,998](/filings/0001193125-26-371311.md) |
| Cost of revenue | $m | [1,298](/filings/0000950170-24-131050.md) | [1,788 d](/filings/0001193125-26-116001.md) | [1,331](/filings/0000950170-25-079172.md) | [1,408](/filings/0001579298-25-000010.md) | [1,418](/filings/0001193125-25-297249.md) | [1,868 d](/filings/0001193125-26-116001.md) | [1,405](/filings/0001193125-26-245274.md) | [1,520](/filings/0001193125-26-371311.md) | [1,510](/filings/0001193125-25-297249.md) | [2,052 d](/filings/0001193125-26-116001.md) | [1,595](/filings/0001193125-26-245274.md) | [1,614](/filings/0001193125-26-371311.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [827](/filings/0000950170-24-131050.md) | [931 d](/filings/0001193125-26-116001.md) | [825](/filings/0000950170-25-079172.md) | [864](/filings/0001579298-25-000010.md) | [893](/filings/0001193125-25-297249.md) | [965 d](/filings/0001193125-26-116001.md) | [868](/filings/0001193125-26-245274.md) | [950](/filings/0001193125-26-371311.md) | [948](/filings/0001193125-25-297249.md) | [1,052 d](/filings/0001193125-26-116001.md) | [989](/filings/0001193125-26-245274.md) | [1,019](/filings/0001193125-26-371311.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | [17.8](/filings/0001193125-25-297249.md) | [18.5 d](/filings/0001193125-26-116001.md) | [15.8](/filings/0001193125-26-245274.md) | [17.4](/filings/0001193125-26-371311.md) | [19.2](/filings/0001193125-25-297249.md) | [18.7 d](/filings/0001193125-26-116001.md) | [16.5](/filings/0001193125-26-245274.md) | [19.7](/filings/0001193125-26-371311.md) |
| Income tax | $m | [18.3](/filings/0000950170-24-131050.md) | [86.1 d](/filings/0001193125-26-116001.md) | [31.1](/filings/0000950170-25-079172.md) | [25.9](/filings/0001579298-25-000010.md) | [27.4](/filings/0001193125-25-297249.md) | [86.7 d](/filings/0001193125-26-116001.md) | [32.0](/filings/0001193125-26-245274.md) | [33.1](/filings/0001193125-26-371311.md) | [33.3](/filings/0001193125-25-297249.md) | [107 d](/filings/0001193125-26-116001.md) | [27.9](/filings/0001193125-26-245274.md) | [57.8](/filings/0001193125-26-371311.md) |
| Net income | $m | [48.6](/filings/0000950170-24-131050.md) | [227 d](/filings/0001193125-26-116001.md) | [78.5](/filings/0001193125-25-297249.md) | [73.8](/filings/0001193125-25-297249.md) | [90.6](/filings/0001193125-25-297249.md) | [261 d](/filings/0001193125-26-116001.md) | [101](/filings/0001193125-26-371311.md) | [94.2](/filings/0001193125-26-371311.md) | [105](/filings/0001193125-25-297249.md) | [310 d](/filings/0001193125-26-116001.md) | [115](/filings/0001193125-26-371311.md) | [184](/filings/0001193125-26-371311.md) |
| Diluted EPS | $ per share | [0.75](/filings/0000950170-24-131050.md) | not reported | [1.22](/filings/0000950170-25-079172.md) | [1.15](/filings/0001579298-25-000010.md) | [1.40](/filings/0001193125-25-297249.md) | not reported | [1.58](/filings/0001193125-26-245274.md) | [1.47](/filings/0001193125-26-371311.md) | [1.63](/filings/0001193125-25-297249.md) | not reported | [1.79](/filings/0001193125-26-245274.md) | [2.88](/filings/0001193125-26-371311.md) |
| Basic EPS | $ per share | [0.75](/filings/0000950170-24-131050.md) | not reported | [1.23](/filings/0000950170-25-079172.md) | [1.16](/filings/0001579298-25-000010.md) | [1.43](/filings/0001193125-25-297249.md) | not reported | [1.60](/filings/0001193125-26-245274.md) | [1.49](/filings/0001193125-26-371311.md) | [1.66](/filings/0001193125-25-297249.md) | not reported | [1.83](/filings/0001193125-26-245274.md) | [2.93](/filings/0001193125-26-371311.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0000950170-24-131050.md) | [0.9](/filings/0000950170-25-040472.md) | [0.7](/filings/0000950170-25-079172.md) | [0.7](/filings/0001579298-25-000010.md) | [0.9](/filings/0001193125-25-297249.md) | [1.0](/filings/0001193125-26-116001.md) | [0.4](/filings/0001193125-26-245274.md) | [0.7](/filings/0001193125-26-371311.md) | [0.6](/filings/0001193125-25-297249.md) | [1.2](/filings/0001193125-26-371311.md) | [0.7](/filings/0001193125-26-245274.md) | [0.7](/filings/0001193125-26-371311.md) |
| Current assets | $bn | [2.2](/filings/0000950170-24-131050.md) | [2.3](/filings/0000950170-25-040472.md) | [2.2](/filings/0000950170-25-079172.md) | [2.3](/filings/0001579298-25-000010.md) | [2.7](/filings/0001193125-25-297249.md) | [2.6](/filings/0001193125-26-116001.md) | [2.1](/filings/0001193125-26-245274.md) | [2.6](/filings/0001193125-26-371311.md) | [2.7](/filings/0001193125-25-297249.md) | [2.8](/filings/0001193125-26-371311.md) | [2.5](/filings/0001193125-26-245274.md) | [2.6](/filings/0001193125-26-371311.md) |
| Total assets | $bn | [7.5](/filings/0000950170-24-131050.md) | [7.7](/filings/0000950170-25-040472.md) | [7.7](/filings/0000950170-25-079172.md) | [7.8](/filings/0001579298-25-000010.md) | [8.4](/filings/0001193125-25-297249.md) | [8.8](/filings/0001193125-26-116001.md) | [8.5](/filings/0001193125-26-245274.md) | [9.3](/filings/0001193125-26-371311.md) | [9.6](/filings/0001193125-25-297249.md) | [9.9](/filings/0001193125-26-371311.md) | [9.8](/filings/0001193125-26-245274.md) | [10.0](/filings/0001193125-26-371311.md) |
| Current liabilities | $bn | [2.0](/filings/0000950170-24-131050.md) | [2.0](/filings/0000950170-25-040472.md) | [2.1](/filings/0000950170-25-079172.md) | [2.2](/filings/0001579298-25-000010.md) | [2.3](/filings/0001193125-25-297249.md) | [2.3](/filings/0001193125-26-116001.md) | [2.0](/filings/0001193125-26-245274.md) | [2.1](/filings/0001193125-26-371311.md) | [2.2](/filings/0001193125-25-297249.md) | [2.2](/filings/0001193125-26-371311.md) | [2.2](/filings/0001193125-26-245274.md) | [2.2](/filings/0001193125-26-371311.md) |
| Long-term debt | $bn | not reported | [1.4](/filings/0000950170-24-032207.md) | not reported | not reported | not reported | [1.7](/filings/0000950170-25-040472.md) | not reported | not reported | not reported | [2.0](/filings/0001193125-26-116001.md) | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001193125-26-371311.md) | not reported | not reported |
| Shareholders' equity | $bn | [0.9](/filings/0000950170-24-131050.md) | [1.0](/filings/0001193125-26-116001.md) | [1.0](/filings/0001193125-25-297249.md) | [1.1](/filings/0001193125-25-297249.md) | [1.1](/filings/0001193125-25-297249.md) | [1.4](/filings/0001193125-26-371311.md) | [1.4](/filings/0001193125-26-371311.md) | [1.4](/filings/0001193125-26-371311.md) | [1.5](/filings/0001193125-25-297249.md) | [1.8](/filings/0001193125-26-371311.md) | [1.8](/filings/0001193125-26-371311.md) | [2.0](/filings/0001193125-26-371311.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [240 d](/filings/0000950170-24-131050.md) | [599 d](/filings/0001193125-26-116001.md) | [49.4](/filings/0000950170-25-079172.md) | [160 d](/filings/0001579298-25-000010.md) | [110 d](/filings/0001193125-25-297249.md) | [543 d](/filings/0001193125-26-116001.md) | [(28.9)](/filings/0001193125-26-245274.md) | [179 d](/filings/0001193125-26-371311.md) | [143 d](/filings/0001193125-25-297249.md) | [938 d](/filings/0001193125-26-116001.md) | [61.5](/filings/0001193125-26-245274.md) | [273 d](/filings/0001193125-26-371311.md) |
| Capital expenditure | $m | [120 d](/filings/0000950170-24-131050.md) | [188 d](/filings/0001193125-26-116001.md) | [165](/filings/0000950170-25-079172.md) | [196 d](/filings/0001579298-25-000010.md) | [167 d](/filings/0001193125-25-297249.md) | [353 d](/filings/0001193125-26-116001.md) | [410](/filings/0001193125-26-245274.md) | [180 d](/filings/0001193125-26-371311.md) | [253 d](/filings/0001193125-25-297249.md) | [218 d](/filings/0001193125-26-116001.md) | [289](/filings/0001193125-26-245274.md) | [244 d](/filings/0001193125-26-371311.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [52.4 d](/filings/0000950170-24-131050.md) | [103 d](/filings/0001193125-26-116001.md) | [75.6](/filings/0000950170-25-079172.md) | [62.1 d](/filings/0001579298-25-000010.md) | [56.5 d](/filings/0001193125-25-297249.md) | [62.1 d](/filings/0001193125-26-116001.md) | [128](/filings/0001193125-26-245274.md) | [27.3 d](/filings/0001193125-26-371311.md) | [63.3 d](/filings/0001193125-25-297249.md) | [60.2 d](/filings/0001193125-26-116001.md) | [134](/filings/0001193125-26-245274.md) | [88.0 d](/filings/0001193125-26-371311.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [65.5](/filings/0000950170-23-065505.md) | [65.3](/filings/0000950170-24-066612.md) | [65.0](/filings/0000950170-24-101847.md) | [64.8](/filings/0000950170-24-131050.md) | [64.3](/filings/0000950170-25-079172.md) | [64.3](/filings/0001579298-25-000010.md) | [64.6](/filings/0001193125-25-297249.md) | [64.0](/filings/0001193125-26-245274.md) | [63.9](/filings/0001193125-26-371311.md) | [64.1](/filings/0001193125-25-297249.md) | [64.1](/filings/0001193125-26-245274.md) | [63.9](/filings/0001193125-26-371311.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 62,815,195 at 2026-08-01, from the cover of the [10-Q filed 2026-08-27](/filings/0001193125-26-371311.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.